Net Cash Provided by (Used in) Operating Activities |
-764K |
USD |
-7.22% |
Jun 30, 2023 |
Q2 2023 |
Net Cash Provided by (Used in) Financing Activities |
596K |
USD |
-44.3% |
Jun 30, 2023 |
Q2 2023 |
Net Cash Provided by (Used in) Investing Activities |
-129K |
USD |
-70% |
Jun 30, 2023 |
Q2 2023 |
Common Stock, Shares Authorized |
10B |
shares |
+1329% |
Dec 31, 2022 |
Q4 2022 |
Common Stock, Shares, Issued |
1.8B |
shares |
+356% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.21K |
USD |
-97.6% |
Dec 31, 2023 |
Q4 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
2.3M |
USD |
+76.7% |
Jun 30, 2023 |
Q2 2023 |
Depreciation |
3.01K |
USD |
-78.5% |
Sep 30, 2023 |
Q3 2023 |
Payments to Acquire Property, Plant, and Equipment |
82.3K |
USD |
+8.86% |
Jun 30, 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Jun 30, 2022 |
Q2 2022 |
Additional Paid in Capital |
4.54M |
USD |
-12.6% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
10M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
998K |
USD |
+76% |
Jun 30, 2023 |
Q2 2023 |
Depreciation, Depletion and Amortization |
3.01K |
USD |
-78.5% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Share-based Payment Arrangement, Expense |
965K |
USD |
|
Jun 30, 2022 |
Q2 2022 |
Interest Expense |
281K |
USD |
+31.5% |
Dec 31, 2023 |
Q4 2023 |